Latest Solazyme Inc (SZYM) Headlines
Solazyme (SZYM) in Focus: Stock Moves 6.8% Higher - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Mar 12, 8:21AM CDT
Solazyme, Inc. (SZYM) was a big mover last session, as the company saw its shares rise by almost 7% on the day.
Nasdaq stocks posting largest percentage increases
AP - Tue Mar 11, 5:02PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage gainers on Nasdaq at the close of trading:
Can This Algae Investment Lower American Manufacturing Costs (and Make You Rich)?
Maxx Chatsko, The Motley Fool - Motley Fool - Tue Mar 11, 1:00PM CDT
Algae technologies may have encountered some dark and cold times in recent years, but they aren't dead yet. Source: BioProcess Algae. Many companies have tried their hand at cultivating photosynthetic algae in massive outdoor facilities -- a list...
Can These 3 Companies Save the Biofuels Business?
Jason Hall, The Motley Fool - Motley Fool - Sun Mar 09, 8:00AM CDT
Energy. Oil . It's at the very heart of everything that drives modern society. It's much more than just the black stuff that comes out of the ground and then goes into our cars. Oil is central to every consumer good we buy, the medical devices we...
'Mad Money' Lightning Round: Zynga Can Go Higher
at The Street - Sat Mar 08, 5:00AM CST
Cramer is staying away from Solazyme but thinks Retrophin is too frothy.
Jim Cramer's 'Mad Money' Recap: Next Week's Game Plan
at The Street - Fri Mar 07, 7:17PM CST
Cramer will be watching a number of conferences for a read on the economy.
Will Biofuels Be at the Core of the Next Manhattan Project?
Shamus Funk, The Motley Fool - Motley Fool - Thu Mar 06, 8:10AM CST
Biofuels are big business, but investors shouldn't expect biofuels to replace petroleum-based fuels on a large scale anytime soon, despite efforts from both large corporations like ExxonMobil and DuPont , as well as smaller companies like KiOR ...
Why Solazyme Inc Slipped This Morning
Brian Pacampara, The Motley Fool - Motley Fool - Tue Mar 04, 8:30AM CST
While Fools should generally take the opinion of Wall Street with a grain of salt, it's not a bad idea to take a closer look at particularly stock-shaking upgrades and downgrades -- just in case their reasoning behind the call makes sense. ...
Solazyme to Present at Two Upcoming Investor Conferences
Business Wire - Mon Mar 03, 8:15AM CST
Solazyme, Inc. (NASDAQ:SZYM), a renewable oil and bioproducts company, today announced its participation in the Raymond James 35th Annual Institutional Investors Conference and the Morgan Stanley 2014 Technology, Media & Telecom Conference. Details of the company's presentations include:
How Designer Microbes and the Organism Industry Will Reshape Our World
Maxx Chatsko, The Motley Fool - Motley Fool - Sun Mar 02, 12:50PM CST
By the end of the decade, products created from microorganisms will be in 90% of American households. Source: Amyris. What would a computer be without transistors? Well, not much. A similar question can be asked of next-generation industrial...
Solazyme Follows Amyris Results With Impressive Developments of Its Own
Maxx Chatsko, The Motley Fool - Motley Fool - Thu Feb 27, 1:20PM CST
This will be a busy year for next-generation industrial biotech platforms enabled by synthetic biology. Things started with a bang earlier this week when synthetic biology pioneer Amyris announced that it had achieved impressive progress exiting...
Solazyme Reports Fourth Quarter and Full Year 2013 Results
Business Wire - Wed Feb 26, 3:05PM CST
--Moema Facility Commissioning
Attention, Solazyme Investors: Don't Forget About Amyris
Maxx Chatsko, The Motley Fool - Motley Fool - Wed Feb 26, 10:14AM CST
What do investors love about industrial biotech company Solazyme ? It offers the potential for tremendous growth -- from revenue of nearly $50 million in 2013 to more than $1 billion in the next several years -- and possesses a truly disruptive...
5 Hated Earnings Stocks You Should Love
at The Street - Tue Feb 25, 12:24PM CST
These heavily shorted stocks could get squeezed much higher on bullish earnings.
4 Green Technology Stocks That Could Be Next Week's Big Movers
Brian Stoffel, The Motley Fool - Motley Fool - Sun Feb 23, 1:30PM CST
As our planet's natural resources get stretched thinner and thinner, companies that can provide the technology to help power our future -- and help us adapt to new realities -- stand to gain a lot of cash. So, too, do the shareholders in those...
How Solazyme, Inc. and Amyris, Inc. Bring Stability to a Risky World
Maxx Chatsko, The Motley Fool - Motley Fool - Thu Feb 20, 9:57AM CST
Solazyme and Amyris should be on everyone's investing radar in 2014. The industrial biotech duo is utilizing synthetic biology to create renewable products with unparalleled quality, consistency, and reliability at commercial scale (that's the...
Harris & Harris Group Announced as Top Ranked High-Tech Investor by SBIR Source and as an Investor in Innovation by Forbes.com
GlobeNewswire - Wed Feb 19, 12:21PM CST
Harris & Harris Group, Inc. (Nasdaq:TINY), an investor in transformative companies enabled by disruptive science, is pleased to announce that we have been ranked #1 by SBIR Source as the Top Investor in High-Technology. The article discusses in detail the Small Business Innovation Research ("SBIR") funding program, which funds cutting edge technology and research with commercial applications. SBIR funding, according to GrantIQ, "is a very strong indicator that companies are high tech or hard tech." Harris & Harris Group topped the rankings based on the percentage of SBIR-backed companies in their historical portfolios and weighted according to the number of companies in each portfolio. The detailed rankings and methodologies used to derive them can be accessed at http://sbirsource.com/sbir/investors/.
Big Companies Are Buying Into Biofuels
Shamus Funk, The Motley Fool - Motley Fool - Sun Feb 16, 2:52PM CST
A handful of smaller companies like Solazyme , Amyris , and Renewable Energy Group are often credited as being the future of biofuels, while many experts in the biofuel industry argue that a monumental investment would be necessary for biofuels...
Solazyme, Inc. and Amyris, Inc. Will Make Sluggish Economic Growth a Distant Memory
Maxx Chatsko, The Motley Fool - Motley Fool - Fri Feb 14, 2:00PM CST
Solazyme and Amyris are disrupting the world's approach to manufacturing commodity chemicals, specialty chemicals, and fuels. Their industrial biotech platforms create drop-in renewable products from engineered industrial organisms that can...
Solazyme to Announce Fourth Quarter and Full Year 2013 Financial Results on February 26, 2014
Business Wire - Wed Feb 12, 8:20AM CST
Solazyme, Inc. (NASDAQ:SZYM), a Renewable(TM) oil and bioproducts company, today announced it will host a conference call and webcast on Wednesday, February 26, 2014 at 4:30 p.m. Eastern Time to discuss its fourth quarter and full year 2013 financial results.
Solazyme (SZYM) in Focus: Stock Moves 6.8% Higher - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Mar 12, 8:21AM CDT
Solazyme, Inc. (SZYM) was a big mover last session, as the company saw its shares rise by almost 7% on the day.
Nasdaq stocks posting largest percentage increases
AP - Tue Mar 11, 5:02PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage gainers on Nasdaq at the close of trading:
Can This Algae Investment Lower American Manufacturing Costs (and Make You Rich)?
Maxx Chatsko, The Motley Fool - Motley Fool - Tue Mar 11, 1:00PM CDT
Algae technologies may have encountered some dark and cold times in recent years, but they aren't dead yet. Source: BioProcess Algae. Many companies have tried their hand at cultivating photosynthetic algae in massive outdoor facilities -- a list...
Can These 3 Companies Save the Biofuels Business?
Jason Hall, The Motley Fool - Motley Fool - Sun Mar 09, 8:00AM CDT
Energy. Oil . It's at the very heart of everything that drives modern society. It's much more than just the black stuff that comes out of the ground and then goes into our cars. Oil is central to every consumer good we buy, the medical devices we...
'Mad Money' Lightning Round: Zynga Can Go Higher
at The Street - Sat Mar 08, 5:00AM CST
Cramer is staying away from Solazyme but thinks Retrophin is too frothy.
Jim Cramer's 'Mad Money' Recap: Next Week's Game Plan
at The Street - Fri Mar 07, 7:17PM CST
Cramer will be watching a number of conferences for a read on the economy.
Will Biofuels Be at the Core of the Next Manhattan Project?
Shamus Funk, The Motley Fool - Motley Fool - Thu Mar 06, 8:10AM CST
Biofuels are big business, but investors shouldn't expect biofuels to replace petroleum-based fuels on a large scale anytime soon, despite efforts from both large corporations like ExxonMobil and DuPont , as well as smaller companies like KiOR ...
Why Solazyme Inc Slipped This Morning
Brian Pacampara, The Motley Fool - Motley Fool - Tue Mar 04, 8:30AM CST
While Fools should generally take the opinion of Wall Street with a grain of salt, it's not a bad idea to take a closer look at particularly stock-shaking upgrades and downgrades -- just in case their reasoning behind the call makes sense. ...
Solazyme to Present at Two Upcoming Investor Conferences
Business Wire - Mon Mar 03, 8:15AM CST
Solazyme, Inc. (NASDAQ:SZYM), a renewable oil and bioproducts company, today announced its participation in the Raymond James 35th Annual Institutional Investors Conference and the Morgan Stanley 2014 Technology, Media & Telecom Conference. Details of the company's presentations include:
How Designer Microbes and the Organism Industry Will Reshape Our World
Maxx Chatsko, The Motley Fool - Motley Fool - Sun Mar 02, 12:50PM CST
By the end of the decade, products created from microorganisms will be in 90% of American households. Source: Amyris. What would a computer be without transistors? Well, not much. A similar question can be asked of next-generation industrial...
Solazyme Follows Amyris Results With Impressive Developments of Its Own
Maxx Chatsko, The Motley Fool - Motley Fool - Thu Feb 27, 1:20PM CST
This will be a busy year for next-generation industrial biotech platforms enabled by synthetic biology. Things started with a bang earlier this week when synthetic biology pioneer Amyris announced that it had achieved impressive progress exiting...
Solazyme Reports Fourth Quarter and Full Year 2013 Results
Business Wire - Wed Feb 26, 3:05PM CST
--Moema Facility Commissioning
Attention, Solazyme Investors: Don't Forget About Amyris
Maxx Chatsko, The Motley Fool - Motley Fool - Wed Feb 26, 10:14AM CST
What do investors love about industrial biotech company Solazyme ? It offers the potential for tremendous growth -- from revenue of nearly $50 million in 2013 to more than $1 billion in the next several years -- and possesses a truly disruptive...
5 Hated Earnings Stocks You Should Love
at The Street - Tue Feb 25, 12:24PM CST
These heavily shorted stocks could get squeezed much higher on bullish earnings.
4 Green Technology Stocks That Could Be Next Week's Big Movers
Brian Stoffel, The Motley Fool - Motley Fool - Sun Feb 23, 1:30PM CST
As our planet's natural resources get stretched thinner and thinner, companies that can provide the technology to help power our future -- and help us adapt to new realities -- stand to gain a lot of cash. So, too, do the shareholders in those...
How Solazyme, Inc. and Amyris, Inc. Bring Stability to a Risky World
Maxx Chatsko, The Motley Fool - Motley Fool - Thu Feb 20, 9:57AM CST
Solazyme and Amyris should be on everyone's investing radar in 2014. The industrial biotech duo is utilizing synthetic biology to create renewable products with unparalleled quality, consistency, and reliability at commercial scale (that's the...
Harris & Harris Group Announced as Top Ranked High-Tech Investor by SBIR Source and as an Investor in Innovation by Forbes.com
GlobeNewswire - Wed Feb 19, 12:21PM CST
Harris & Harris Group, Inc. (Nasdaq:TINY), an investor in transformative companies enabled by disruptive science, is pleased to announce that we have been ranked #1 by SBIR Source as the Top Investor in High-Technology. The article discusses in detail the Small Business Innovation Research ("SBIR") funding program, which funds cutting edge technology and research with commercial applications. SBIR funding, according to GrantIQ, "is a very strong indicator that companies are high tech or hard tech." Harris & Harris Group topped the rankings based on the percentage of SBIR-backed companies in their historical portfolios and weighted according to the number of companies in each portfolio. The detailed rankings and methodologies used to derive them can be accessed at http://sbirsource.com/sbir/investors/.
Big Companies Are Buying Into Biofuels
Shamus Funk, The Motley Fool - Motley Fool - Sun Feb 16, 2:52PM CST
A handful of smaller companies like Solazyme , Amyris , and Renewable Energy Group are often credited as being the future of biofuels, while many experts in the biofuel industry argue that a monumental investment would be necessary for biofuels...
Solazyme, Inc. and Amyris, Inc. Will Make Sluggish Economic Growth a Distant Memory
Maxx Chatsko, The Motley Fool - Motley Fool - Fri Feb 14, 2:00PM CST
Solazyme and Amyris are disrupting the world's approach to manufacturing commodity chemicals, specialty chemicals, and fuels. Their industrial biotech platforms create drop-in renewable products from engineered industrial organisms that can...
Solazyme to Announce Fourth Quarter and Full Year 2013 Financial Results on February 26, 2014
Business Wire - Wed Feb 12, 8:20AM CST
Solazyme, Inc. (NASDAQ:SZYM), a Renewable(TM) oil and bioproducts company, today announced it will host a conference call and webcast on Wednesday, February 26, 2014 at 4:30 p.m. Eastern Time to discuss its fourth quarter and full year 2013 financial results.
